发明公开
- 专利标题: SHORT INTERFERING NUCLEIC ACID (SINA) MOLECULES CONTAINING A 2' INTERNUCLEOSIDE LINKAGE
-
申请号: EP17001972.3申请日: 2014-02-20
-
公开(公告)号: EP3366772A1公开(公告)日: 2018-08-29
- 发明人: Chang, Wonsuk , Guidry, Erin, N. , Stanton, Matthew, G. , Zewge, Daniel
- 申请人: Sirna Therapeutics, Inc.
- 申请人地址: 300 Third Street Cambridge, MA 02142 US
- 专利权人: Sirna Therapeutics, Inc.
- 当前专利权人: Sirna Therapeutics, Inc.
- 当前专利权人地址: 300 Third Street Cambridge, MA 02142 US
- 代理机构: Müller-Boré & Partner Patentanwälte PartG mbB
- 优先权: US201361767837P 20130222
- 主分类号: C12N15/11
- IPC分类号: C12N15/11 ; C07H21/04 ; C07H21/02 ; C07H21/00
摘要:
The present invention relates to RNAi molecules, and compositions thereof, comprising a 2' internucleoside linkage connecting the nucleotide at position 1 and the nucleotide at position 2 at the 5' end of the antisense strand. Specifically, the invention relates to single- and double-stranded short interfering nucleic acid (siNA) molecules that are capable of mediating RNA interference comprising 5' modified nucleotides that comprise, among other potential modifications, a 2' internucleoside linkage. The invention further relates to 5' modified nucleotides used as reagents to generate the RNAi molecules of the invention and methods of using the disclosed RNAi molecules.
信息查询
IPC分类: